BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23061573)

  • 1. Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.
    Robertson C; Rose S; Kesselheim AS
    J Law Med Ethics; 2012; 40(3):452-66. PubMed ID: 23061573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.
    Sah S
    J Law Med Ethics; 2012; 40(3):482-7. PubMed ID: 23061575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The General Medical Council and doctors' financial interests.
    Adlington K; Abbasi K; Godlee F
    BMJ; 2015 Jan; 350():h474. PubMed ID: 25630755
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 5. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 6. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 7. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of disclosing financial ties in research and clinical care: a systematic review.
    Licurse A; Barber E; Joffe S; Gross C
    Arch Intern Med; 2010 Apr; 170(8):675-82. PubMed ID: 20421551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry relationships with physicians under scrutiny.
    Beller GA
    J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
    [No Abstract]   [Full Text] [Related]  

  • 13. Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.
    Holloway RG; Mooney CJ; Getchius TS; Edlund WS; Miyasaki JO
    Neurology; 2008 Jul; 71(1):57-63. PubMed ID: 18591506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential conflicts of interest in the delivery of medical services: an analysis of the situation and a proposal.
    Herschberg S
    Qual Assur Util Rev; 1992; 7(2):54-8. PubMed ID: 1609013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of interest. Profits and problems in physician referrals.
    Morreim EH
    JAMA; 1989 Jul; 262(3):390-4. PubMed ID: 2661874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of explicit financial incentives on physician behavior.
    Armour BS; Pitts MM; Maclean R; Cangialose C; Kishel M; Imai H; Etchason J
    Arch Intern Med; 2001 May; 161(10):1261-6. PubMed ID: 11371253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medical trade.
    Bawaskar HS
    Indian J Med Ethics; 2013; 10(4):278. PubMed ID: 24152357
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory test ordering at physician offices with and without on-site laboratories.
    Bishop TF; Federman AD; Ross JS
    J Gen Intern Med; 2010 Oct; 25(10):1057-63. PubMed ID: 20532656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.